Previous Article | Next Article 
J Virol. 1992 February; 66(2): 1273-1276
Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood.
T F Schwarz,
S Serke,
B Hottenträger,
A von Brunn,
H Baurmann,
A Kirsch,
W Stolz,
D Huhn,
F Deinhardt and
M Roggendorf
Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilian University, Munich, Germany.
ABSTRACT
Erythroid progenitor cells generated in vitro from peripheral human blood in the presence of interleukin-3 and erythropoietin were infected with human parvovirus B19. B19 virus DNA replication was highest 48 to 72 h after infection, and maximum levels of B19 virus proteins were detected in culture supernatants at 72 to 96 h after infection. B19 virus propagated in vitro was infectious. This cell culture system with peripheral blood cells facilitates studies in vitro of B19 virus replication.
J Virol. 1992 February; 66(2): 1273-1276
This article has been cited by other articles:
-
Wong, S., Zhi, N., Filippone, C., Keyvanfar, K., Kajigaya, S., Brown, K. E., Young, N. S.
(2008). Ex Vivo-Generated CD36+ Erythroid Progenitors Are Highly Permissive to Human Parvovirus B19 Replication. J. Virol.
82: 2470-2476
[Abstract]
[Full Text]
-
Heegaard, E. D., Brown, K. E.
(2002). Human Parvovirus B19. Clin. Microbiol. Rev.
15: 485-505
[Abstract]
[Full Text]
-
Weigel-Kelley, K. A., Yoder, M. C., Srivastava, A.
(2001). Recombinant Human Parvovirus B19 Vectors: Erythrocyte P Antigen Is Necessary but Not Sufficient for Successful Transduction of Human Hematopoietic Cells. J. Virol.
75: 4110-4116
[Abstract]
[Full Text]
-
Kerr, J. R
(2000). Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis
59: 672-683
[Full Text]
Copyright © 1992 by the American Society for Microbiology. All rights reserved.